Accelmed

Accelmed is a global group of funds investing and acquiring control in HealthTech companies (medical devices, diagnostics, digital health, and technology-enabled services). Accelmed Partners is a US-based lower market private equity HealthTech fund, focused on Buyout and Non-Control transactions in commercial-stage HealthTech companies (>$10M LTM revenue). We invest in de-risked commercial growth stage companies that have resolved their development/technical risks; clinical risks; regulatory risks; and reimbursement risks. Our primary focus is on reducing the execution risk. We partner with excellent management teams that can benefit from Accelmed Partner’s vast experience in the HealthTech industry.